Abstract: . . .  reviewed the meeting objectives (listed above) and noted the Secretary’s interest in receiving a completed report by the end of the year.  He acknowledged the challenge the Committee faces in working past their differences to complete the paper on time.  Dr. Schechtman emphasized that a Federal advisory committee is most valuable when, even in the presence of diverse views, it can present a picture of where consensus exists. Dr. Layton welcomed members of the Committee and expressed her desire to complete most of the substantive work on the paper by the end of the meeting.  She reminded . . .
. . .  Regulatory Consumers role has increased Players in the full food production chain more involved Global trade Governing future agricultural biotechnology products in order to provide these products a fair and equitable chance in the marketplace. Vision Committee members may have different visions of how central to American agriculture biotechnology will be in the future but all members envision agricultural biotechnology products as important and part of a diverse marketplace. Suggested Alternative language: “AC21 members share a . . .
. . .  agricultural biotechnology products in order to provide these products a fair and equitable chance in the marketplace. Vision Committee members may have different visions of how central to American agriculture biotechnology will be in the future but all members envision agricultural biotechnology products as important and part of a diverse marketplace. Suggested Alternative language: “AC21 members share a vision of a diversified agricultural marketplace, sensitive to and able to meet the needs and preferences of customers and consumers in the United States and the . . .
. . .  share the hope that the potential for transgenic derived products will be achieved and provide new products that are safe and acceptable to consumers, processors and farmers.  In the United States, consumer acceptance will depend on whether the new products offer direct and substantial benefits and whether consumers are confident that the regulatory system assures the products are safe.” Relevance to USDA ( Note : transition paragraph to discuss the relevance to USDA of the next section, Topics Discussed)  . . .
. . .  October 24-25, 2005 Room 107A, USDA Jamie L. Whitten Building Washington, D.C. Meeting Summary   On October 24 - 25, 2005, the United States Department of Agriculture (USDA) convened the tenth plenary meeting of the Advisory Committee on Biotechnology and 21 st Century Agriculture (AC21). The meeting objectives were: To introduce a new Committee member, Russell Kremer To continue on-going work towards completion of a paper examining the impacts of agricultural biotechnology on American agriculture and USDA over the next five-to-ten years, . . .
--3000,5,300,3313,31926